Carmai Seto

The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K

Jacques Yves Gauthier, Nathalie Chauret, Wanda Cromlish et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 467 citations · Full text

Molecular Pharmacology, Pharmaceutical Chemistry, Biochemistry +11

Discovery of a Potent and Selective Prostaglandin D₂ Receptor Antagonist, [(3<i>R</i>)-4-(4-Chloro- benzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta[<i>b</i>]indol-3-yl]-acetic Acid (MK-0524)

Claudio F. Sturino, Gary P. O’Neill, Nicolas Lachance et al. · Journal of Medicinal Chemistry · 2007 · 170 citations · Full text

Microdosing Assessment to Evaluate Pharmacokinetics and Drug Metabolism in Rats Using Liquid Chromatography-Tandem Mass Spectrometry

Jinsong Ni, Hui Ouyang, Mauro Aiello et al. · Pharmaceutical Research · 2008 · 43 citations

Preclinical Drug Evaluation, Medicine, Drug Purity +9

β-Substituted Cyclohexanecarboxamide:  A Nonpeptidic Framework for the Design of Potent Inhibitors of Cathepsin K

Sheldon N. Crane, W. Cameron Black, James T. Palmer et al. · Journal of Medicinal Chemistry · 2006 · 36 citations · Full text

Low energy collisionally activated dissociation of Cu2+(glycine)(H2O), Cu2+(glycine)(H2O)2, Cu2+(glycine)2, and Cu2+(glycylglycine)2

Carmai Seto, John A. Stone · International Journal of Mass Spectrometry · 1999 · 31 citations

Inorganic Chemistry, Engineering, Activated Dissociation +10